Viewing Study NCT01922258


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-05-21 @ 9:01 AM
Study NCT ID: NCT01922258
Status: COMPLETED
Last Update Posted: 2020-11-20
First Post: 2013-08-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Agitation Associated With View
None Alzheimer's Disease View
None Alzheimer's Type View
None Mental Disorder View
None Nervous System Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OPC-34712 View
None brexpiprazole View
None Dementia View
None Alzheimer's Disease View
None Cognitive Disorders View
None Agitation View